RADIOPHARM ORDINARY (RAD) Short Interest

Name: RADIOPHARM ORDINARY (RAD) Short Position History
Creator: Shorted
License: https://creativecommons.org/licenses/by/4.0/

RADIOPHARM ORDINARY (ASX:RAD) had 0.06% of shares reported as short positions as of 5 June 2026, representing 2,005,926 shares. RADIOPHARM ORDINARY operates in the Pharmaceuticals, Biotechnology & Life Sciences industry. Source: ASIC short position report (T+4 delay).

Short interest: 0.06%
Reported positions: 2,005,926
Industry: Pharmaceuticals, Biotechnology & Life Sciences
As of: 5 June 2026

Source: official ASIC short position report, T+4 delay. Methodology · Disclaimer — not financial advice.

RAD

Radiopharm Theranostics

Pharmaceuticals, Biotechnology & Life Sciences

Radiopharm Theranostics is a clinical-stage radiotherapeutics company focused on developing a pipeline of first-in-class radiopharmaceuticals for the diagnosis and treatment of cancer. The company aims to transform cancer care by delivering innovative solutions for earlier detection and personalized treatment of cancers with unmet needs.

Radiopharmaceuticals

Theranostics

Oncology

Clinical Stage

Shorted

short percentage0.06%

reported shorts2M

shares on issue3.544B